Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy
Condition(s):Lymphoma,; Non-Hodgkin Lymphoma,; Extranodal NK/T-cell Lymphoma,Nasal-type,Last Updated:September 30, 2014Unknown status
Hide Studies Not Open or Pending
Condition(s):Lymphoma,; Non-Hodgkin Lymphoma,; Extranodal NK/T-cell Lymphoma,Nasal-type,Last Updated:September 30, 2014Unknown status
Condition(s):Brain HypoxiaLast Updated:March 19, 2019Completed
Condition(s):Mild Traumatic Brain InjuryLast Updated:August 8, 2018Completed
Condition(s):Mild Traumatic Brain InjuryLast Updated:December 11, 2023Recruiting
Condition(s):Mild Traumatic Brain Injury; Concussion, Mild; Academic Achievement; Specific Academic or Work Inhibition; Marriage; Marital Status; Income; Education; Socioeconomic Status; Sickness AbsenceLast Updated:March 14, 2019Completed
Condition(s):Mild Cognitive ImpairmentLast Updated:January 17, 2024Not yet recruiting
Condition(s):Mild Cognitive ImpairmentLast Updated:December 7, 2023Withdrawn
Condition(s):Mild Cognitive ImpairmentLast Updated:July 26, 2017Unknown status
Condition(s):Subarachnoid Hemorrhage, AneurysmalLast Updated:October 18, 2016Withdrawn
Condition(s):Brain Injuries; Craniocerebral TraumaLast Updated:March 12, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.